Packaging made with anti-fog additives offers the transparency and fog prevention required to confidently present fresh foods to consumers (English language version) Enables effective package separation and improve manufacturing operations such as mold release during thermoforming and packaging pick and place operations (Chinese language version) Chemically Compatible TPEs for Cosmetic Packaging - Application Bulletin

Packaging made with anti-fog additives offers the transparency and fog prevention required to confidently present fresh foods to consumers (English language version) Enables effective package separation and improve manufacturing operations such as mold release during thermoforming and packaging pick and place operations (Chinese language version) Chemically Compatible TPEs for Cosmetic Packaging - Application Bulletin

Packaging made with anti-fog additives offers the transparency and fog prevention required to confidently present fresh foods to consumers (English language version) Enables effective package separation and improve manufacturing operations such as mold release during thermoforming and packaging pick and place operations (Chinese language version) Chemically Compatible TPEs for Cosmetic Packaging - Application Bulletin

We are a premier provider of specialty polymer formulations, color and additive systems, and packaging solutions.  Our global network of product stewardship and regulatory compliance specialists includes experts on regulations covering foods, beverages, drugs, cosmetics, medical devices, consumer goods, toys, packaging, chemical and waste management. We serve multiple industries from healthcare and transportation to packaging and beyond with colorants and additives for thermoplastics, TPEs, high temperature resins, and fluoropolymers along with dispersions for thermosets.

Protective equipment like masks and sterile packaging help to prevent disease transmission, while critical devices like ventilators and CPAP machines work to save lives. Mevopur™ Chemical Foaming Agents (CFA) enable reduced material use, while meeting regulatory requirements for medical devices and pharmaceutical packaging. Remafin™ EP White Colorants for Pharmaceutical Packaging designed for a range of pharmaceuticals, safeguarding light transmission while meeting regulatory requirements.

Its exhibit will include application successes covering drug delivery, diagnostics, pharmaceutical packaging, and surgical devices.   •    Specific formulations for pharmaceutical packaging or drug delivery based on ingredients tested to USP661.1, European Pharmacopeia 3.1, and ICHQ3D extractable metals Examples include: •    Barrier technologies that preserve the shelf-life and quality of food, beverages, medicine and other perishable goods through high-performance materials that require less plastic •    Light-weighting solutions that replace heavier traditional materials like metal, glass and wood, which can improve fuel efficiency in all modes of transportation •    Breakthrough technologies that minimize wastewater and improve the recyclability of materials and packaging across a spectrum of end uses

Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials. The raw materials are pre-tested to the relevant chapters of ISO 10991, USP 661, USP Class VI, EP 3.1 and to the ICH Q3D guidelines to help manufacturers increase the certainty of regulatory compliance for their devices and packaging. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials. The raw materials are pre-tested to the relevant chapters of ISO 10991, USP 661, USP Class VI, EP 3.1 and to the ICH Q3D guidelines to help manufacturers increase the certainty of regulatory compliance for their devices and packaging. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials. The raw materials are pre-tested to the relevant chapters of ISO 10991, USP 661, USP Class VI, EP 3.1 and to the ICH Q3D guidelines to help manufacturers increase the certainty of regulatory compliance for their devices and packaging. Help protect or enhance the performance of polymers used in medical devices, diagnostics and pharmaceutical packaging.

As discussed in furff ther detail in the “Compensation Discussion and Analysis”, equity compensation represents a significant portion of the compensation package forff our Chief Executive Officer and other named executive offiff cers. Newlin’s total compensation package among the peer companies and across the broader general industry.